Drug: Tocilizumab Injury: Rheumatoid arthritis Quarter: 2016Q3
Total Records: 7 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
88137376 | Tocilizumab | Rheumatoid arthritis | ROCHE | 64.08 YR | F | 95 KG | 20160909 | CA |
98550562 | Tocilizumab | Rheumatoid arthritis | ROCHE | 0.00 | F | 0 | 20160920 | FR |
122526483 | Tocilizumab | Rheumatoid arthritis | ROCHE | 47.00 YR | F | 0 | 20160725 | DE |
125870801 | Tocilizumab | Rheumatoid arthritis | ROCHE | 76.42 YR | F | 0 | 20160725 | IT |
126706771 | Tocilizumab | Rheumatoid arthritis | ROCHE | 74.00 YR | F | 0 | 20160822 | AU |
126750511 | Tocilizumab | Rheumatoid arthritis | ROCHE | 0.00 | F | 0 | 20160823 | GB |
126815761 | TOCILIZUMAB | Rheumatoid arthritis | INTERCHEM | 74.00 YR | F | 0 | 20160824 | AU |
Total Records: 7 Number of Pages: 1